Transform Your Clinical Trials In Eastern Europe With New Comprehensive Industry Pages™ Report

If you're planning to conduct clinical trials in Central and Eastern Europe, we have great news for you. OCT Clinical, a leading CRO in Eastern Europe, has released its latest annual report, Industry Pages™, exclusively for Clinical Leader subscribers.

Industry Pages™ is a comprehensive report that provides you with valuable insights and insider knowledge on the clinical research market in Central and Eastern Europe. The report collates data from numerous public sources, including regulatory authorities, and provides you with a single document that will help you make informed decisions about your clinical trials.

With the U.S. Food and Drug Administration approving 37 novel drugs in 2022, out of which 25 underwent clinical trials involving research sites in Central and Eastern European countries, this region is quickly becoming a popular destination for clinical trials.

By downloading Industry Pages™, you will find out:

• The latest updates on the clinical trial landscape in Central and Eastern Europe
• The reasons why global pharma favors the region among others
• FDA data on clinical research
• Enrollment statistics within the region
• The current status of the EU Clinical Trial Regulation for CTIS.